NCT03770923View on ClinicalTrials.gov

Effect of Some Drugs on Rheumatoid Arithritis Activity

PHASE3RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Rupatadine

Rupatadine 10 mg daily

DRUG

Montelukast

Montelukast 10 mg daily

Trial Locations (1)

35111

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors
lead

Sherief Abd-Elsalam

OTHER

NCT03770923 - Effect of Some Drugs on Rheumatoid Arithritis Activity | Biotech Hunter | Biotech Hunter